Summary. To determine whether adenosine is involved in long-term regulation of glucose transport in adipose tissue, we have investigated effects of administration of an adenosine receptor antagonist (theophylline) on adipocyte glucose transport. Rats were injected with theophylline (30mg/kg, dissolved in 0.9% NaC1) daily for 7 days. Controls were injected with saline. The rats were then killed, and epididymal adipocytes were isolated. Insulin-stimulated glucose transport rates were decreased by about 25%-30% in the cells from theophylline-treated rats at all insulin concentrations tested. The halfmaximally effective concentration of insulin was not altered (6.5 + 0.5 and 6.7 + 0.5 mU/1 in control and treated cells respectively), suggesting a post-insulin binding defect. This was confirmed by the finding that 125I-insulin binding to the cells was not altered. Adenosine receptor number and affinity (measured on detergent-solubilized adipocyte extracts using 12SI-hydroxyphenylisopropyl adenosine) was also not changed by theophyUine treatment. We conclude that theophylline administration causes decreased glucose transport rates in rat adipocytes at a post-insulin binding level. Thus, chronic adenosine receptor blockade impairs adipocyte glucose transport, suggesting that adenosine is involved in longterm regulation of glucose metabolism in adipose tissue.
The methyl xanthines (theophylline, caffeine, etc.) have many effects in vitro. However, it is now believed that most, if not all, of the effects of methyl xanthines observed in vivo are due to antagonism of cell-surface adenosine receptors [1, 2] . Adenosine is present in most mammalian tissues [3] and has been implicated as an important endogenous regulator of the actions of several hormones [3, 4] . Of particular interest are the findings that adenosine is released by isolated adipocytes [5, 6] and can increase the sensitivity of these cells to the actions of insulin on glucose transport [7, 8] and oxidation [9] . Adenosine has also been proposed to be an important regulator of lipolyis, both in rat [10] and human [11] adipose tissue.
In addition to the acute in vitro effects of adenosine on insulin sensitivity described above, it has been proposed that chronic alterations in adenosine or adenosine receptor concentration may be involved in the altered insulin sensitivities associated with metabolic states such as starvation, adrenalectomy, obesity and Type2 (non-insulin-dependent) diabetes [12] . To address specifically the involvement of adenosine in chronic regulation of insulin action, we have investigated the effect of adenosine receptor blockade with theophylline on adipocyte glucose transport.
Materials and methods

Chemicals
Porcine insulin was generously given by Dr. M. Root of Eli Lilly (Indianapolis, Ind, USA). Bovine serum albumin (type CRG-7) was purchased from Armour Pharmaceutical (Kankakee, Ill, USA). Collagenase (type CLS) was from Worthington Biochemical (Freehold, N J, USA). Silicone oil (density 0.99 g/ml) was purchased from A. H. Thomas (Philadelphia, Pa, USA). 2-deoxy-D-[1-3H] glucose and (-)N6-(3-[125I]-iodo-4-hydroxyphenylisopropyl) adenosine (125I-HPIA) were from Amersham Corporation (Arlington Heights, Ill, USA). Hepes (N-2-hydroxyelthylpiperazine-N 1-2-ethanesulfonic acid), adenosine deaminase (type III), theophylline, 2-deoxy-D-glucose, phloretin, polyethylene glycol (PEG; molecular weight approx. 8,000) bovine gammaglobulin, and 3-[(3-cholamidopropyl)-dimethylammoniol]-1-propane-sulfonate (Chaps) were from Sigma,Chemical Co. (St. Louis, Mo, USA). Unlabelled HPIA was from Boehringer Mannheim Biochemicals (Indianapolis, Ind, USA).
Animal treatments
Male Sprague-Dawley rats weighing 182 + 2 g (mean _+ SEM) were randomized into groups of 6. The animals were injected intraperitoneally with theophylline (30 mg/kg, dissolved in 0.9% NaC1) each day at 11.00 hours. Control animals were injected with an equivalent volume of 0.9% NaC1. The treatment period was 7 days. At 09.00 hours on day 8, the animals were killed by a blow to the head followed by cervical dislocation, and epididymal fat pads were removed.
Isolation of adipocytes
Adipocytes were liberated from the epididymal fat pads by a modification of the method of Rodbell [13] as follows. The tissue was minced with scissors and then incubated at 37 ~ for 1 h in a buffer containing 137 mmol/1 NaC1, 5 mmol/1 KC1, 4.2 mmol/1 NaHCO3, 1.3 retool/1 CaC12, 0.5 retool/1 KH2PO4, 0.5 mmol/1 MgC12, 0.4mmol/1 MgSO4, 5 mmol/1 glucose, 20 mmol/1 Hepes, pH 7.4 plus bovine serum albumin (40 mg/ml) and collagenase (1.5 mg/ml). The digested tissue was filtered through 1000 ~tm nylon mesh, centrifuged (25 g for 90 s) and washed three times with the appropriate buffer for glucose transport or insulin binding studies (see below).
Glucose transport assay
Uptake of 2-deoxyglucose was used as an index of the rate of glucose transport [14] . Adipocytes (approximately 300,000 cells in 1 ml) were incubated with shaking for 45 min at 37 ~ in the same buffer as described above, except that the bovine serum albumin concentration was 10mg/ml and there was no collagenase or glucose. Additions were as described in the text and figure legends.
At the end of the incubation period, 2-deoxy-D-[1-3H]-glucose (sp radioact 1.6 Ci/mol) was added (final concentration 0.1 mmol/1). The assays were terminated 3 min later by transferring 300 ~tl samples of the cell suspension to plastic microtubes containing silicone oil (50 lal). The tubes were centrifuged for 30 s in a Beckman Microfuge, and the assay was considered terminated when centrifugation began. The tubes were cut through the oil layer with a razor blade, and the radioactivity in the cell pellet was measured in a liquid scintillation counter. In each experiment, the amount of 2-deoxygtucose trapped non-specifically in the cell layer was determined by measuring uptake in the presence of 0.3 mmol/1 phloretin, which completely inhibits glucose transport [15] . All data for 2-deoxyglucose uptake have been corrected by subtraction of this value.
Insulin receptor assay
Insulin was iodinated by the chloramine T method and purified on a column of Sephadex G-50 [16] . The specific activity of the iodinated insulin was approximately 150-180 txCi/Ixg.
Adipocytes were suspended in a buffer similar to that used for tissue digestion, except that the albumin concentration was 10 mg/ml, the pH was 7.8 and there was no collagenase. Cells were incubated with 125I-insulin (7.5 mU/1) plus various concentrations of unlabeled insulin for 2.5 h at 16 ~ Binding of 125I-insulin was determined as previously described [8, 17] .
Adenosine receptor assay
Total cellular adenosine receptors were assayed on detergent-solubilized cell extracts using 125I-labeled hydroxyphenyl isopropyl adenosine [18, 19] as follows. Adipocytes suspended in the glucose transport buffer (1 ml, containing approximately 300,000 cells) were centrifuged (25 gfor 90 s) and the buffer was removed. The cells were then solubilized in 50 mmol/1 Hepes, 0.15 tool/1 NaC1, 10 mmol/1 MgC12, 0.5% Chaps, pH 7.6 (volume equal to that of the packed cell volume) for 45 min at 37 ~ The cell suspension was mixed on a vortex mixer every 10 rain during the solubilizing step. After solubilizing, the cell suspension was centrifuged for 5 min in a Beckman Microfuge, and the aqueous layer was separated from the triglyceride and insoluble precipitated material.
Adenosine receptors were assayed on 30 ~tl samples of the solul~le extract. The total assay volume was 70 ~xl and contained, at final concentrations, 50 mmol/1 Hepes, pH 7.6, 10 mmol/1 MgC12, 0.15 mol/1 NaCI, 0.2 nmol/1 a25I-HPIA (approx 0.03 IxCi/assay) 10 p~g/ml adenosine deaminase and 0-100 nmol/1 unlabelled HPIA. The tubes were incubated for 2.5 h at 37 ~ and then the bound radioactivity was precipitated with polyethylene glycol as follows. Bovine gamma globulin solution (20 ~tl of 12.5 mg/ml in 50 mmol/1 Hepes, pH 7.6) was added as cartier, followed by 500 txl of icecold 15% (w/v) polyethylene glycol. The tubes were mixed thoroughly and then duplicate 200-~d sampies were transferred to plastic 300 lxl microtubes containing 50 Ixl of 15% polyethylene glycol. The tubes were centrifuged in a Beckman Microfuge for 3 min. The tips of the microtubes, containing the precipitated material, were cut with a razor blade and transferred to 12 x 75 mm polystyrene tubes for measurement of radioactivity in a gamma-counter. For each extract, non-specific binding was measured in the presence of a large excess of HPIA (10 Ixmol/1). Non-specific binding was approximately 5-10% of total binding (0.5-1% of total radioactivity). All data have been corrected by subtraction of non-specific binding.
D NA assays
To allow for variations in cell concentration, all data have been normalized to DNA. DNA was assayed by a modification of the method of Burton [20] as follows. Triplicate 1 ml samples of cell suspensions were extracted 3times with 10% (w/v) HC103. The extracts were pooled, and 2.3 ml of 4% diphenylamine in glacial acetic acid, followed by 0.115 ml of acetaldehyde solution (1.6 mg/ml in H20) were added. The tubes were incubated at 56 ~ for 1 h, cooled on ice and then extracted with 1.5 ml amyl acetate. Standards containing 0-20 p~g DNA were run in parallel. The optical densities of the organic phase were measured at 595 nm.
Statistical analysis
All data were analyzed by Student's ttest. Values of p<0.05 were judged statistically significant. Levels of significance are given in the figure legends. 
Results
Effect of theophylline on weight gain and fat pad size
The data in Table 1 demonstrate that administration of theophylline for 7 days had no significant effect on either total body weight or weight of the epididymal fat pads.
Insulin receptors
Competition curves of 125I-insulin binding to adipocytes isolated from control and theophylline-treated rats are shown in Figure 1 . The curves are almost identical for the two groups of rats, indicating that theophylline treatment did not significantly alter insulin receptors.
Adenosine receptors
Figure2 shows competition curves of 125I-hydroxyphenylisoprophyl adenosine binding to detergent-solubiiized extracts of adipocytes from control and theophylline-treated rats. This radioactive ligand is known to bind specifically to the A1 adenosine receptor (see Discussion). In contrast to its effect on brain [21, 22] , theophylline did not cause an increase in the number of adenosine receptors in adipocytes, as evidenced by the almost superimposable competition curves ( Figure 2 ).
Glucose transport
Glucose transport (2-deoxyglucose uptake) rates in the presence of 0-625mU/1 insulin, in adipocytes from control and theophylline-treated rats, are shown in Figure 3 . Since adipocytes spontaneously release adenosine [5, 6] , measurements were performed both in the absence and presence of adenosine deaminase to determine whether any observed effects were due to differences in factors such as adenosine release. Figure 3 a shows glucose transport in the absence of adenosine deaminase. It is clear that the glucose transport rate is lower in the adipocytes from theophyllinetreated rats than in cells from untreated animals. This decreased rate is apparent at each insulin concentration including the basal (although the latter was not statistically significant). Furthermore, the magnitude of the difference is approximately equal at each insulin concentration; transport rates in the ceils from treated rats are approximately 25% lower than in controls.
The half-maximally effective concentration of insulin was calculated from the insulin dose-response curve of each individual rat. This value was not altered in the theophylline-treated animals as compared to controls (6.7 + 0.5 mU/1 and 6.5 + 0.5 mU/1 respectively).
As in the absence of adenosine deaminase (above), the glucose transport rate was lower in the cells from theophylline-treated rats when measured in the presence of the enzyme (Fig.3b) . Adenosine deaminase caused a marked shift to the fight in the insulin dose-response curve for glucose transport, as we have previously reported [7, 8] . However, there was again no difference in the ECs0 for insulin in the cells from control and treated rats (52 + 7 mU/1 and 52 __. 5 mU/l respectively).
Since the decreased glucose transport rate in adipocytes from theophylline-treated rats is evident both in the absence and in the presence of adenosine deaminase, these findings suggest that the lowered transport rate is intrinsic to the cells, rather than being due to differences in adenosine release in vitro.
Discussion
The findings demonstrate that a 7-day administration of theophylline to rats caused decreased glucose transport rates in adipocytes at all insulin concentrations. The basal rate was also decreased, although this was not statistically significant. Theophylline did not alter the halfmaximally effective concentration of insulin, and insulin binding was unaltered. We therefore conclude that the decreased transport rate is due to a post-insulin binding defect. The insulin receptor possesses a tyrosine-specific protein kinase activity which has been proposed to be involved in insulin action [23, 24] . It is possible that theophylline alters the activity of this kinase, and so it is not clear whether the findings are due to a true post-receptor defect. However, since the responsiveness of the cells to insulin was decreased, rather than the insulin sensitivity, it is more likely that the insulin resistance is due to a decrease in total glucose transporters.
It is believed that the in vivo effects of methyl xanthines are mediated via inhibition of adenosine receptors [1, 2] . These adenosine receptors can be sub-divided into 2 classes: A1 receptors are usually inhibitory to adenylate cyclase, while A2 receptors are usually sfimulatory [25, 26] . Rat adipocytes possess primarily Aa receptors. Theophylline is equally potent at A1 and A2 receptors, with IC50 values in the range of 5-40 ~tmol/l [27] . Therefore, the current findings suggest that chronic blockade of adipocyte adenosine receptors leads to decreased glucose transport rates, and hence that adenosine chronically increases glucose transport rates in adipose tissue. Adenosine is known to be a potent inhibitor of adipocyte lipolysis [5, 11] ; increases the sensitivity of these cells to effects of insulin on glucose transport [7, 8] , glucose oxidation and lipolysis [9] ; and blocks certain actions of catecholamines [28] and glucagon [7] . The current findings suggest a further role for adenosine in regulation of adipocyte metabolism, i.e. the chronic maintenance of glucose transport rates.
As outlined above, it is probable that the mechanism by which theophylline administration decreases glucose transport rates is related to antagonism of adenosine action. The exact mechanism by which this occurs is not dear, since the acute response to adenosine is increased insulin sensitivity, rather than responsiveness. However, these two effects may be related, since chronic hypoinsulinaemia causes decreased responsiveness of glucose transport to insulin [29] while chronic hyperinsulinaemia has the opposite effect [30] . Thus, it is possible 191 that blocking adenosine receptors chronically decreases the sensitivity of adipocytes to insulin, creating a Situation similar to chronic hypoinsulinaemia.
An alternative explanation for the findings is that the effects of theophylline are due to chronic elevation of cyclic AMP levels. Adenosine inhibits adenylate cyclase in adipocytes [4, 25, 26] . Therefore, chronic theophylline treatment would be expected to increase adipocyte cyclic AMP. Indeed, the most easily demonstrated effect of methyl xanthines in vivo is increased plasma free fatty acid concentrations [31] , probably secondary to lipolysis and hence cyclic AMP in adipose tissue. The conclusion that this effect is due to blockade of adenosine receptors is evidenced by the finding that the order of potency among several methyl xanthines exactly parallels their order of potency as adenosine receptor antagonists [31] . There was no relation to their potency as phosphodiestase inhibitors.
Using protocols similar to that in the current study, Fredholm [21] and Murray [22] demonstrated up-regulation of adenosine receptors in brain following caffeine or theophylline treatment. We found no change in adipocyte adenosine receptors. Similarly, Fredholm [21] demonstrated that the inhibitory effect of N6-phenylisopropyl adenosine on adipocyte lipolysis was not potentiated following chronic caffeine administration, although the number of receptors in the brain was increased by 25-30%. Thus, it appears that adipocyte adenosine receptors differ from the brain receptors in that they do not up-regulate in response to methyl xanthines.
Evidence is presented that adenosine can chronically increase the insulin responsiveness of adipose tissue, at a post-insulin binding level. This may be relevant to conditions such as obesity and Type 2 diabetes, which are associated with post-insulin receptor defects in insulin action [32, 33] . There is evidence that changes in adenosine are involved in the insulin resistance of adipose tissue in obesity. Firstly, adipose tissue from obese mice has a decreased activity of 5' nucleotidase (an enzyme involved in adenosine production) but increased activities of adenosine deaminase and adenosine kinase (which metabolize adenosine) as compared to lean controis [12] . This suggests that adipose tissue adenosine concentrations are low in obesity. Secondly, it has been demonstrated that lipolysis in adipocytes from obese human subjects is less sensitive to inhibition by N6-phenylisopropyl adenosine than in cells from lean individuals [34] , suggesting adenosine receptor number or affinity may be decreased in obesity. Thus, a rationale for treatment of these conditions may be to develop agents which increase tissue adenosine or adenosine receptor concentrations. However, it should be pointed out that adenosine acutely decreases the insulin sensitivity of skeletal muscle [35] . This tissue difference may be due to a predominance of A2 receptors in muscle, as compared to A1 receptors in adipose tissue. Thus, it is likely that tissue-specific, or receptor-specific, agents would have to be developed for such an approach to be effective in the treatment of insulin resistance.
